Information
-
Patent Application
-
20230295080
-
Publication Number
20230295080
-
Date Filed
July 13, 20213 years ago
-
Date Published
September 21, 2023a year ago
-
Inventors
-
Original Assignees
-
CPC
-
-
International Classifications
- C07C319/08
- C12P13/12
- C12N9/10
Abstract
The present invention relates to a process for synthesizing functionalized mercaptans essentially in the absence of oxygen, and also to a composition making it possible in particular to implement this process. Said functionalized mercaptans are of the following formula (I):
Claims
- 1. Process for synthesizing at least one functionalized mercaptan of the following general formula (I):
in which,R1 and R7, which are identical or different, are a hydrogen atom or an aromatic or nonaromatic, linear, branched or cyclic, saturated or unsaturated, hydrocarbon chain of 1 to 20 carbon atoms which may comprise one or more heteroatoms;X is chosen from -C(=O)-, -CH2- or -CN;R2 is:
(i) either absent when X represents -CN,(ii) or a hydrogen atom,(iii) or -OR3, R3 being a hydrogen atom or an aromatic or nonaromatic, linear, branched or cyclic, saturated or unsaturated, hydrocarbon chain of 1 to 20 carbon atoms which may comprise one or more heteroatoms,(iv) or -NR4R5, R4 and R5, which are identical or different, being a hydrogen atom or an aromatic or nonaromatic, linear, branched or cyclic, saturated or unsaturated, hydrocarbon chain of 1 to 20 carbon atoms which may comprise one or more heteroatoms;n is equal to 1 or 2; and * represents an asymmetric carbon;
said process comprising the steps of:
a) provision of at least one compound of the following general formula (II):
in which *, R1, R2, R7, X and n are as defined for formula (I) and
G represents either (i) R6-C(O)-O-, or (ii) (R70)(R8O)-P(O)-O-, or (iii) R9O-SO2-O-; withR6 being a hydrogen atom or a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain of 1 to 20 carbon atoms which may comprise one or more aromatic groups and may be substituted by one or more groups chosen from -OR10, (=O), -C(O)OR11, -NR12R13;R10, R11, R12 and R13 being independently chosen from:
H or a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain of 1 to 20 carbon atoms;R7 and R8, which are identical or different, being a proton, an alkali metal, an alkaline earth metal or an ammonium;R9 being chosen from a proton, an alkali metal, an alkaline earth metal or an ammonium;b) provision of at least one hydrosulfide salt and/or sulfide salt or H2S;c) reaction between said at least one compound of formula (II) and said at least one hydrosulfide and/or sulfide salt or H2S in the presence of at least one enzyme chosen from sulfhydrylases, and preferably a sulfhydrylase associated with said compound of formula (II); said reaction being performed essentially in the absence of oxygen, preferably in the absence of oxygen;d) obtaining of at least one functionalized mercaptan of formula (I);e) optional separation of said at least one functionalized mercaptan of formula (I) which is obtained in step d); andf) optional additional functionalization and/or optional deprotection of the functionalized mercaptan of formula (I) which is obtained in step d) or e); and wherein steps a) and b) are optionally performed simultaneously.
- 2. Synthesis process according to claim 1, wherein step c) takes place in a reactor in which the reaction mixture comprises less than 0.0015% oxygen by weight relative to the total weight of the reaction mixture and/or the gas phase contained in the gas headspace of the reactor comprises less than 21% oxygen by volume relative to the total volume of said gas phase.
- 3. Synthesis process according to claim 1, wherein the hydrosulfide salt and/or sulfide salt or H2S is in excess relative to the compound of formula (II), preferably during step c).
- 4. Synthesis process according to claim 1, wherein the molar ratio [hydrosulfide salt and/or sulfide salt] / [compound of formula (II)] or H2S/compound of formula (II) is comprised between 1.5 and 10, preferentially between 2 and 8, and even more preferentially between 3.5 and 5, limits included, preferably during step c).
- 5. Synthesis process according to claim 1, wherein said at least one hydrosulfide and/or sulfide salt is chosen from the group consisting of: ammonium hydrosulfide, alkali metal hydrosulfides, alkaline earth metal hydrosulfides, alkali metal sulfides and alkaline earth metal sulfides.
- 6. Synthesis process according to claim 1, wherein the pH of the reaction medium in step c) is comprised between 4 and 9, for example between 5 and 8, preferably between 6 and 7.5, and more particularly between 6.2 and 7.2, limits included.
- 7. Synthesis process according to claim 1, wherein the compound of formula (II) is chosen from the group consisting of: O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O-acetoacetyl-L-homoserine, O-propio-L-homoserine, O-coumaroyl-L-homoserine, O-malonyl-L-homoserine, O-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine and O-sulfato-L-homoserine, preferably O-acetyl-L-homoserine.
- 8. Process according to claim 1, wherein said compound of formula (II) is O-acetyl-L-homoserine, the enzyme used is O-acetyl-L-homoserine sulfhydrylase and the functionalized mercaptan of formula (I) is L-homocysteine.
- 9. Process according to claim 1, wherein said sulfhydrylase is a transferase of the E.C.2. type.
- 10. Composition, preferably solution, comprising:
a compound of formula (II) as defined in claim 1;a sulfhydrylase, preferably a sulfhydrylase associated with the compound of formula (II); andammonium hydrosulfide NH4SH or H2S in excess.
Priority Claims (2)
Number |
Date |
Country |
Kind |
FR2007577 |
Jul 2020 |
FR |
national |
FR2012669 |
Dec 2020 |
FR |
national |
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/FR2021/051300 |
7/13/2021 |
WO |
|